86 related articles for article (PubMed ID: 18642355)
1. The metalloproteinase-disintegrin ADAM10 is exclusively expressed by type I muscle fibers.
Dehmel T; Goebel HH; Hartung HP; Lehmann H; Wiendl H; Kieseier BC
Muscle Nerve; 2008 Aug; 38(2):1049-51. PubMed ID: 18642355
[TBL] [Abstract][Full Text] [Related]
2. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
3. Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque composition by shifting the balance from inflammation toward fibrosis.
van der Vorst EP; Jeurissen M; Wolfs IM; Keijbeck A; Theodorou K; Wijnands E; Schurgers L; Weber S; Gijbels MJ; Hamers AA; Dreymueller D; Rose-John S; de Winther MP; Ludwig A; Saftig P; Biessen EA; Donners MM
Am J Pathol; 2015 Apr; 185(4):1145-55. PubMed ID: 25659879
[TBL] [Abstract][Full Text] [Related]
4. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
[TBL] [Abstract][Full Text] [Related]
5. A-Disintegrin-And-Metalloproteinase (ADAM) 10 Activity on Resting and Activated Platelets.
Facey A; Pinar I; Arthur JF; Qiao J; Jing J; Mado B; Carberry J; Andrews RK; Gardiner EE
Biochemistry; 2016 Mar; 55(8):1187-94. PubMed ID: 26840909
[TBL] [Abstract][Full Text] [Related]
6. A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression.
Zhang W; Liu S; Liu K; Wang Y; Ji B; Zhang X; Liu Y
J Int Med Res; 2014 Jun; 42(3):611-8. PubMed ID: 24670536
[TBL] [Abstract][Full Text] [Related]
7. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.
Pruessmeyer J; Ludwig A
Semin Cell Dev Biol; 2009 Apr; 20(2):164-74. PubMed ID: 18951988
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ADAM 10 and ADAM 12 in lesional psoriatic skin.
Oh ST; Schramme A; Stark A; Tilgen W; Gutwein P; Reichrath J
Br J Dermatol; 2008 Jun; 158(6):1371-3. PubMed ID: 18363768
[No Abstract] [Full Text] [Related]
9. A Disintegrin and Metalloprotease 10 (ADAM10) Is Indispensable for Maintenance of the Muscle Satellite Cell Pool.
Mizuno S; Yoda M; Shimoda M; Tohmonda T; Okada Y; Toyama Y; Takeda S; Nakamura M; Matsumoto M; Horiuchi K
J Biol Chem; 2015 Nov; 290(47):28456-28464. PubMed ID: 26453297
[TBL] [Abstract][Full Text] [Related]
10. ADAM10 as a target for anti-cancer therapy.
Moss ML; Stoeck A; Yan W; Dempsey PJ
Curr Pharm Biotechnol; 2008 Feb; 9(1):2-8. PubMed ID: 18289051
[TBL] [Abstract][Full Text] [Related]
11. Increased ADAM10 expression in preeclamptic placentas is associated with decreased expression of hydrogen sulfide production enzymes.
Hu T; Wang G; Zhu Z; Huang Y; Gu H; Ni X
Placenta; 2015 Aug; 36(8):947-50. PubMed ID: 26021209
[TBL] [Abstract][Full Text] [Related]
12. Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney.
Schramme A; Abdel-Bakky MS; Gutwein P; Obermüller N; Baer PC; Hauser IA; Ludwig A; Gauer S; Schäfer L; Sobkowiak E; Altevogt P; Koziolek M; Kiss E; Gröne HJ; Tikkanen R; Goren I; Radeke H; Pfeilschifter J
Kidney Int; 2008 Aug; 74(3):328-38. PubMed ID: 18480749
[TBL] [Abstract][Full Text] [Related]
13. The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10.
Lemieux GA; Blumenkron F; Yeung N; Zhou P; Williams J; Grammer AC; Petrovich R; Lipsky PE; Moss ML; Werb Z
J Biol Chem; 2007 May; 282(20):14836-44. PubMed ID: 17389606
[TBL] [Abstract][Full Text] [Related]
14. Adam10 mediates the choice between principal cells and intercalated cells in the kidney.
Guo Q; Wang Y; Tripathi P; Manda KR; Mukherjee M; Chaklader M; Austin PF; Surendran K; Chen F
J Am Soc Nephrol; 2015 Jan; 26(1):149-59. PubMed ID: 24904084
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling-Degos disease.
Kono M; Sugiura K; Suganuma M; Hayashi M; Takama H; Suzuki T; Matsunaga K; Tomita Y; Akiyama M
Hum Mol Genet; 2013 Sep; 22(17):3524-33. PubMed ID: 23666529
[TBL] [Abstract][Full Text] [Related]
16. The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling.
Weber S; Niessen MT; Prox J; Lüllmann-Rauch R; Schmitz A; Schwanbeck R; Blobel CP; Jorissen E; de Strooper B; Niessen CM; Saftig P
Development; 2011 Feb; 138(3):495-505. PubMed ID: 21205794
[TBL] [Abstract][Full Text] [Related]
17. Cleavage of the human thyrotropin receptor by ADAM10 is regulated by thyrotropin.
Kaczur V; Puskas LG; Nagy ZU; Miled N; Rebai A; Juhasz F; Kupihar Z; Zvara A; Hackler L; Farid NR
J Mol Recognit; 2007; 20(5):392-404. PubMed ID: 18074395
[TBL] [Abstract][Full Text] [Related]
18. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
Harris B; Pereira I; Parkin E
Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
[TBL] [Abstract][Full Text] [Related]
19. A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells.
Wolpert F; Tritschler I; Steinle A; Weller M; Eisele G
Neuro Oncol; 2014 Mar; 16(3):382-91. PubMed ID: 24327582
[TBL] [Abstract][Full Text] [Related]
20. Membrane-enabled dimerization of the intrinsically disordered cytoplasmic domain of ADAM10.
Deng W; Cho S; Su PC; Berger BW; Li R
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):15987-92. PubMed ID: 25349418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
